GlassScriptPhysician profile
George C Bailey
NPI 1538422779
$1,837.17
in general payments reported to CMS, 2019-2025
38 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $180 · 2021: $527 · 2022: $327 · 2023: $160 · 2024: $92.70 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $270.48 | 2019-2022 | |
| Boston Scientific Corporation | $179.19 | 2019-2023 | Rezum Generator |
| Astellas Pharma US INC | $147.25 | 2019-2023 | Myrbetriq |
| Antares Pharma, INC. | $120.35 | 2019-2022 | |
| Emd Serono, INC. | $110.49 | 2021 | |
| Abbvie INC. | $103.86 | 2022-2025 | Botox |
| Pfizer INC. | $66.03 | 2021-2022 | |
| Neotract INC. | $56.76 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $56.46 | 2020-2022 | |
| Axonics, INC. | $55.64 | 2020-2021 | |
| Coloplast Corp | $51.96 | 2019-2021 | |
| Biotissue Holdings INC. | $49.93 | 2022 | |
| Olympus America INC. | $48.18 | 2021-2024 | Itind System |
| Sun Pharmaceutical Industries INC. | $43.74 | 2022 | |
| Procept Biorobotics Corporation | $42.58 | 2021-2025 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $30.90 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $28.30 | 2020 | |
| Biotronik Nro, INC. | $23.88 | 2025 | Prospera |
| Calyxo, INC. | $23.50 | 2023 | Cvac Aspiration System |
| Endo USA, INC. | $23.42 | 2024 | Xiaflex |
| Abbott Laboratories | $21.80 | 2024 | Proclaim |
| Clovis Oncology, INC. | $20.68 | 2020 | |
| Janssen Biotech, INC. | $19.88 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $19.36 | 2022 | |
| Travere Therapeutics, INC. | $19.12 | 2019 | |
| Myovant Sciences INC. | $18.86 | 2021 | |
| Urogen Pharma, INC. | $18.81 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.54 | 2019 | |
| Blue Earth Diagnostics | $17.44 | 2021 | |
| Octapharma USA, INC. | $17.32 | 2025 | Octagam Immune Globulin (Human) |
| Verity Pharmaceuticals INC. | $16.98 | 2024 | Trelstar |
| Medtronic USA, INC. | $15.88 | 2019 | |
| Amgen INC. | $15.77 | 2021 | |
| Mission Pharmacal Company | $14.71 | 2021 | |
| Tempus Ai, INC | $13.26 | 2024 | |
| Metuchen Pharmaceuticals | $12.19 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $11.90 | 2019 | |
| Merck Sharp & Dohme LLC | $11.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.